Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Development/Plasticity/Repair

Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia

Yoshihiro Morikawa, Shinobu Tamura, Ken-ichi Minehata, Peter J. Donovan, Atsushi Miyajima and Emiko Senba
Journal of Neuroscience 25 February 2004, 24 (8) 1941-1947; DOI: https://doi.org/10.1523/JNEUROSCI.4975-03.2004
Yoshihiro Morikawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinobu Tamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ken-ichi Minehata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Donovan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atsushi Miyajima
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emiko Senba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Oncostatin M (OSM) is a member of the interleukin-6 family of cytokines, and we have reported previously that the murine OSM receptor β subunit (OSMR) was expressed in some neurons in the adult trigeminal and dorsal root ganglia (DRGs) and in the perineonatal hypoglossal nucleus. In the present study, we investigated the development of OSMR-positive neurons of DRGs in OSM-deficient mice. In situ hybridization revealed that OSMR-positive neurons in DRGs began to appear at postnatal day 0 (P0) and reached the adult level at P14. In the DRGs of the OSM-deficient mice, vanilloid receptor 1 (VR1)- and P2X3-positive small-sized neurons were significantly decreased. In addition, OSMR-positive neurons decreased, resulting in the reduced number of VR1/P2X3/OSMR-triple positive neurons. OSM-deficient mice displayed significantly reduced noxious responses in models of acute thermal, mechanical, chemical, and visceral pain. Thus, OSM plays an essential role in the development of a subtype of nociceptive neurons in the DRGs.

  • oncostatin M
  • receptor
  • dorsal root ganglion
  • Ret
  • VR1
  • P2X3
  • mouse
  • gene-targeting
  • pain
  • behavior

Introduction

Oncostatin M (OSM) is a member of the interleukin-6 (IL-6) family of cytokines that includes IL-6, IL-11, leukemia inhibitory factor (LIF), ciliary neurotrophic factor, cardiotrophin-1, and novel neurotrophin-1/B-cell stimulatory factor-3/cardiotrophin-like cytokine (Taga and Kishimoto, 1997; Heinrich et al., 1998; Senaldi et al., 1999; Elson et al., 2000). These cytokines play important roles in hematopoiesis, inflammation, regulation of the acute phase responses, bone remodeling, heart development, and neurogenesis. Human OSM was originally isolated from a phorbol ester-stimulated human histiocytic lymphoma cell line (Zarling et al., 1986). Although the mouse OSM gene had long been unidentified, its cDNA has been cloned recently as a cytokine-inducible early response gene (Yoshimura et al., 1996).

A unique feature of the IL-6 family is their redundant activities, which are attributed to the shared use of glycoprotein (gp) 130, the common signal-transducing subunit of the receptors for these cytokines (Kishimoto et al., 1995). OSM induces signals through the receptor complex comprising gp130 and the OSM-specific β subunit (OSMR; Mosley et al., 1996; Heinrich et al., 1998). Recently, OSM-specific biological activities mediated through the OSMR, distinct from those of the other IL-6 family of cytokines, have been reported: the proliferation of multipotent hematopoietic progenitors and the formation of endothelial cell clusters possibly by stimulating their common precursors in vitro (Mukouyama et al., 1998; Miyajima et al., 2000), the differentiation of hepatocytes (Kamiya et al., 1999; Miyajima et al., 2000; Matsui et al., 2002), and the expansion of neonatal Sertoli cells (Hara et al., 1998).

We have reported previously that OSMR was widely expressed in various organs, including the nervous system, during murine embryogenesis and in the adult mice (Tamura et al., 2002a, 2003a,b). In dorsal root ganglia (DRGs), OSMR was shown to be expressed in nonpeptidergic nociceptive neurons, which expressed both the vanilloid receptor 1 (VR1) and the P2X3 purinergic receptor (Tamura et al., 2003a). Of the IL-6 family members, OSM and LIF are the most closely related functionally, structurally, and genetically (Gearing, 1993; Gearing et al., 1993; Jeffery et al., 1993). In the peripheral nervous system, LIF is required for the survival and differentiation of embryonic sensory neurons and the appropriate changes in neuronal gene expression after nerve injury (Sun and Zigmond, 1996; Lecomte et al., 1998; Turnley and Bartlett, 2000). During inflammation in peripheral tissues, LIF plays a key role in early anti-inflammatory responses, and exogenous LIF can reduce inflammatory hyperalgesia (Banner et al., 1998). On the other hand, Sugiura et al. (2000) have reported that inflammatory cell infiltration into crushed nerve is significantly slower in LIF knock-out mice. IL-6 is also essential for the maintenance of function and regeneration of sensory neurons (Zhong et al., 1999). Although there are many reports that describe roles of IL-6 family cytokines in the murine peripheral nervous system, little is known about the role of OSM in adult mice. In the present study, we describe the involvement of OSM in the development of a specific subset of nociceptive neurons in murine DRGs.

Materials and Methods

Tissue preparation. Embryonic [embryonic day 11.5 (E11.5), E14.5, and E17.5], postnatal [postnatal day 0 (P0), P7, and P14], and adult (8 weeks old) C57BL/6J male mice (Nihon SLC, Hamamatsu, Japan) were used in the present study. The embryos were removed by cesarean section and immersed in ice-cold 0.1 m phosphate buffer (PB) containing 4% paraformaldehyde (PFA) at 4°C overnight. The postnatal and adult mice were perfused transcardially with ice-cold 0.85% NaCl followed by ice-cold Zamboni's fixative (2% PFA and 0.2% picric acid in 0.1 m PB, pH 7.4) for immunohistochemical staining or 4% PFA in 0.1 m PBS for in situ hybridization. All perfusion fixations were performed under deep anesthesia (diethylether). DRGs (L4/L5) and spinal cord were quickly removed, followed by postfixation at 4°C for 3 hr and finally 20% sucrose in 0.1 m PBS. They were then embedded in OCT medium (Miles, Elkhart, IN) and frozen rapidly in cold n-hexane on dry ice and stored at -80°C.

The experiments were performed under the control of the Animal Research Control Committee in accordance with the Guidelines for Animal Experiments of Wakayama Medical University and Japanese Government Notification on Feeding and Safekeeping of Animals (No. 6). All efforts were made to minimize the number of animals used and their suffering.

Preparation of RNA probe. A 275 bp Asp718-XhoI cDNA fragment (coding region) of OSMR was ligated into a pBluescript II SK(-) vector, which was then linearized by cutting with Asp718 (for the antisense probe) or with XhoI (for the sense probe). In vitro transcription was performed using appropriate RNA polymerase (T3 RNA polymerase for the antisense probe; T7 RNA polymerase for the sense probe) and [α-35S] UTP.

In situ hybridization analysis. In situ hybridization was performed as described previously (Tamura et al., 2002a, 2003b). Briefly, frozen sections were cut on a cryostat at 6 μm thickness. After being hybridized at 55°C for 16 hr with sense and antisense 35S-labelled cRNA probes, the slides were submersed with Kodak NTB-2 liquid emulsion (Kodak, Rochester, NY). The dipped autoradiograms were developed 14 days later and fixed. The sections were counterstained through the emulsion with hematoxylin and eosin, and examined under bright- and dark-field microscopy (XF-WFL, Nikon, Tokyo, Japan).

Immunohistochemical method. Immunohistochemical staining was performed as described previously (Tamura et al., 2003a,b). Slide-mounted 6-μm cryostat tissue sections of DRGs (L4/L5) and 20-μm sections of murine spinal cord were processed for immunohistochemical method. Sections were preincubated in 0.1M PBS containing 10% normal donkey serum at room temperature (RT) for 1 hr, and then incubated with primary antibodies containing 0.5% bovine serum albumin (BSA) and 0.3% Triton X-100 (4°C, overnight). Primary antibodies were used at the following dilutions: goat anti-OSMR, 1:50 (Santa Cruz Biotechnology, Santa Cruz, CA); rabbit anti-VR1, 1:500 (Oncogene, San Diego, CA); rabbit anti-calcitonin gene-related peptide (CGRP), 1:1000 (Amersham, Arlington Heights, IL); rabbit anti-tyrosine kinase (TrkA), 1:100 (Upstate Biotechnology, Lake Placid, NY); rabbit anti-c-receptor tyrosine kinase (Ret), 1:100 (Tamura et al., 2003a); and guinea pig anti-P2X3, 1:1000 (Neuromics, Minneapolis, MN). The next day, sections were washed in 0.1 m PBS containing 0.1% Triton X-100, and were incubated in the Cy2/Cy3-conjugated secondary antibodies (Jackson ImmunoResearch, West Grove, PA), containing 2% normal mouse serum and 0.3% Triton X-100 [room temperature (RT), 1 hr], diluted 1:400. For the avidin-biotin complex method, after the incubation with primary antisera, the sections were incubated in biotinylated donkey anti-goat IgG (Jackson ImmunoResearch), diluted 1:400, containing 0.5% BSA and 0.3% Triton X-100 (RT, 1 hr). After washes with 0.1 m PBS, the sections were incubated with 7-amino-4-methylcoumarin-3-acetic acid-conjugated streptavidin (Jackson ImmunoResearch) in 0.1 m PBS (RT, 1 hr). Immunofluorescence images were acquired using Nikon (Tokyo, Japan) VFM microscope with fluorescent attachment.

Quantitative analysis. For stereological cell counting, L4/L5 DRGs from four perfused mice were pooled and processed for sectioning. Entire DRGs were serially sectioned at 6 μm and stained with NeuroTrace (Molecular Probes, Eugene, OR) at 1:500 dilution for 20 min or 4′,6-diamidino-2-phenylindole dihydrochloride for 5 min for nuclear staining after incubation with secondary antisera. After staining, color digitized images of each section were captured using an epifluorescence microscope (Eclipse E800; Nikon) equipped with a color 3CCD camera (C5810; Hamamatsu Photonics, Shizuoka, Japan). The number of fluorescently labeled cells was counted using Adobe Photoshop software (Adobe Systems, San Jose, CA) under observer-blind conditions.

To obtain unbiased estimates of total dorsal root ganglion (DRG) neurons (stained with NeuroTrace) and VR1- or P2X3-labeled neurons, the physical dissector principle was used to count neurons in a section (Coggeshall, 1992). Briefly, in each DRG, pairs of adjacent sections (reference section and look-up section) were compared. Within a measured area of the section, only neurons with clearly visible nuclei and nucleoli present in the reference section but not the look-up section were counted, and then the neuronal density [number of cells/(measured area × section thickness)] was calculated. For each DRG, every 10th section was analyzed, starting with a randomly chosen section between 1 and 10.

The cross-sectional area occupied by neurons was measured for the DRG (NIH Image, version 1.61), and the volume of each ganglion occupied by neurons (μm3 × 106) was estimated from the area measurements, section thickness, and the total number of sections containing each ganglion. Total numbers of NeuroTrace-stained neurons and numbers of VR1- or P2X3-labeled neurons in the DRG then were determined by multiplying the neuronal density by the total DRG volume (Gundersen et al., 1988).

Cells were outlined manually using a computer mouse to measure the cell size, and cross-sectional areas for outlined cell profiles were quantified using NIH Image, version 1.61. Size-frequency histograms were then generated from counted neurons. The values shown are means ± SEM. All statistical analyses were performed using Student's t test. Significance was determined to be p < 0.05.

Gene targeting the OSM locus. As described previously (M.P. de Miguel, J. M. Centanni, C. Stewart, T. Hara, K. Minehata, M. Embree-Ku, K. Boekelheide, A. Miyajima, and P. J. Donovan, unpublished observations), genomic clones hybridizing to the mouse OSM cDNA were obtained from a λ phage 129/Sv mouse genomic library, which was partially digested with BamHI, MboI, BgIII, or Sau3AI. The targeting vector was constructed by cloning the selected 15.8 Kb clone containing the entire mOSM locus into a pJMM4 plasmid that contained a neomycin resistance cassette driven by the phosphoglycerate kinase (PGK) promoter. The gene targeting strategy was designed to replace the endogenous exon II and coding region of exon III as well as the intervening intron with the PGKNeo gene which introduces diagnostic XbaI and SphI sites into the genomic locus.

Southern analysis and/or PCR was used to genotype the offspring. For Southern analysis, the genomic DNA was digested with SphI and hybridized with a 5′ external probe (600 bp long). The wild-type allele was detected as a 9 kb band, whereas the mutant allele generated a 7 kb band. For PCR genotyping, two sets of primers were used in the same reaction mixture. To amplify a 420 bp fragment of the wild-type OSM allele (420 bp), primers OSMs (CAAGGGAACCCGCAGAATCTG) and OSMa (TGAATCAGCTTGTGTCATCAG) were used. To amplify a 585 bp fragment from the Neo gene in the targeted locus the primers NEOs (GAACAAGATGGATTGCACGCAG) and NEOa (CCATGATATTCGGCAAGCAG) were used. The PCR conditions were 95°C for 2 min and 30 cycles of 94°C for 30 sec, 59°C for 1 min, and 72°C for 1 min, with an extension cycle at 72°C for 10 min.

OSM+/- males were backcrossed at least six generations to C57BL/6 females to place the OSM deficiency on a more nearly isogenic background. OSM+/+ and OSM-/- littermate mice generated from heterozygous intercrosses were used for all experiments.

Behavioral tests. These experiments were approved by the Wakayama Medical University Animal Care and Use Committee.

Chemical nociception was assessed by the capsaicin, αβ-methylene ATP (αβ-meATP), and formalin tests (Dickenson and Sullivan, 1987; Cao et al., 1998; Caterina et al., 2000; Tsuda et al., 2002). For 4 d before these tests, mice were acclimated on the test platform for 2 hr every day. On the day of the study, mice were placed on the test platform for 1 hr and subsequently were administered 10 μl of capsaicin (1-5 mg in 10 ml saline/10% ethanol/0.5% Tween 80; Sigma-Aldrich, St. Louis, MO), 10 μl of αβ-meATP (Sigma, 10 μmol/ml), and 10 μl of 5% formalin in the plantar surface of the left paw for each tests. The time spent either licking or lifting the injected paw was recorded. In the hot-plate assay (Cao et al., 1998; Caterina et al., 2000), mice were first habituated to the hot-plate apparatus with temperature set at 45°C for 2 min. Subsequently, mice were placed on the hot plate (48-58°C) and the response latency to hindpaw licking or to jumping was recorded. The cutoff time was 60 sec for the 52°C hot plate and 30 sec at 58°C. Mechanical sensitivity was assessed by the tail-pinch test (Cao et al., 1998). We determined the latency to respond (lick or bite) to an intense mechanical stimulus by a clip applied to the tail. Responses to visceral stimuli were assessed as the number of abdominal stretches after intraperitoneal injections of 0.6% acetic acid (5 ml/kg; visceral pain with inflammation) or MgSO4 (120 mg/kg; visceral pain without inflammation) (Cao et al., 1998). The frequency of stretch responses was counted for 20 min for acetic acid or for 5 min for MgSO4. Motor function was assessed by using an accelerating Rotarod treadmill (Ugo Basile, Comerio, Italy). The mice are first trained to walk on the rotating rod for 3 min at a speed of 4 rpm. For testing, the speed was set at 4 rpm and subsequently accelerated to 40 rpm. The time taken for mice to fall after the beginning of the acceleration was recorded.

Results

Developmental expression patterns of OSMR in DRG neurons

To examine the developmental expression pattern of OSMR in DRGs, lower lumber DRGs at developmental ages E14.5 to P14 were hybridized to identify neurons expressing OSMR mRNA. OSMR mRNA was not detected in any cells of the DRGs during the embryonic stages (data not shown). OSMR mRNA was first detected in a few cells of the DRGs at P0, gradually increased, and reached the adult level at P14 (Fig. 1).

  Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

In situ hybridization for the detection of OSMR mRNA in developing DRGs at the indicated stages (P0, P7, P14, and adult). A progressive increase in the number of OSMR-positive neurons during early postnatal development was observed. Scale bar, 100 μm.

Decrease of a subset of nociceptive DRG neurons in adult OSM-/- mice

To help define the role of OSM in the development of the mouse DRGs, we used OSM-deficient mice. OSM-/- mice developed normally, and were not distinguishable from their +/+ or +/- littermates in terms of size or weight at any point during their development (data not shown). As described previously (Tamura et al., 2003a), ∼13% of total DRG neurons in normal adult mice were OSMR-positive small-sized neurons, which expressed VR1 and P2X3. Immunohistochemical staining for sensory neuronal markers revealed that the numbers of VR1-positive (OSM+/+, 46.8 ± 1.4%; OSM-/-, 24.0 ± 1.0%; p < 0.001) and P2X3-positive (OSM+/+, 56.3 ± 0.9%; OSM-/-, 46.5 ± 1.2%; p < 0.001) DRG neurons were significantly reduced in the DRGs of the adult OSM-/- mice (Fig. 2). We could not detect significant changes in the number of TrkA- and c-Ret-positive neurons. No changes in the CGRP-positive DRG neurons were also observed in the adult OSM-/- mice (Fig. 2). In addition, analysis of size frequency of total, VR1-positive, and P2X3-positive neurons showed the decrease in the small-sized neurons, which expressed VR1 and P2X3 (Fig. 3), in the DRGs of OSM-/- mice.

  Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Expression of sensory neuronal markers in the DRGs of OSM-/- mice. A series of sections through adult lumbar DRGs of OSM+/+ and OSM-/- mice are shown. Scale bar, 100 μm.

  Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Size-frequency histograms illustrate the distribution of the cross-sectional areas of total (A), VR1-positive (B), and P2X3-positive (C) DRG neurons pooled from four OSM+/+ and OSM-/- mice. No significant differences were noted between the two genotypes except in the small-sized neurons (<300 μm2). *p < 0.05; n = 4.

In a previous report (Tamura et al., 2003a), we demonstrated that all OSMR-positive neurons were VR1/P2X3-double-positive. Double-immunofluorescence staining for VR1 and P2X3 revealed significant reduction of VR1/P2X3-double-positive neurons of DRGs in OSM-/- mice (Fig. 4, arrowheads) (OSM+/+, 26.4 ± 1.8%; OSM-/-, 7.8 ± 1.3%; p < 0.01). In addition, OSMR-positive DRG neurons were also decreased in OSM-/- mice (OSM+/+, 15.2 ± 1.8%; OSM-/-, 7.6 ± 0.6%; p < 0.03), resulting in the reduced VR1/P2X3/OSMR-triple-positive neurons.

  Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Double-immunofluorescence staining of VR1 and P2X3 in the adult DRG of OSM+/+ (left) and OSM-/- (right) mice. VR1/P2X3-double-positive cells (arrowheads) in the merged image are significantly reduced. Scale bar, 100 μm.

To define the laminar localization of VR1 and P2X3 in adult lumbar spinal cord in OSM-/- mice, we performed double-immunofluorescence staining for VR1 and P2X3. The primary afferent fibers expressing VR1 (Fig. 5, green) and P2X3 (Fig. 5, red) are known to be distributed within lamina I-II and within the inner portion of lamina II (lamina IIi), respectively. As shown in Figure 5, in OSM-/- mice, we could detect few VR1/P2X3-double-positive fibers (yellow) within the lamina IIi of the spinal cord, which were clearly detected in OSM+/+ mice.

  Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Double-immunofluorescence staining of VR1 and P2X3 in the dorsal horn of OSM+/+ (left) and OSM-/- (right) adult mice. In OSM+/+ mice, intense double immunoreactivity (yellow) is located in the inner portion of lamina II of the dorsal horn. However, double immunostaining is almost completely absent from the dorsal horn of OSM-/- mice. Scale bar, 200 μm.

Defects in pain sensitivity in adult OSM-/- mice

OSM-/- mice did not exhibit any impairment of motor coordination; retention times using the Rotarod test were 98 ± 6.1 sec for OSM+/+ mice and 104 ± 4.7 sec for OSM-/- mice (n = 6 per group).

To assess nociceptive function experimentally, we performed a battery of behavioral tests on adult OSM-/- mice (Fig. 6). First, we assessed the nociceptive responses to chemical stimuli, including capsaicin, αβ-meATP, and formalin, because the VR1- and P2X3-positive neurons were decreased, as shown in Figures 3 and 4. As expected, the capsaicin stimulus elicited robust licking of the paw in OSM+/+ and OSM+/- mice, but OSM-/- mice showed significantly reduced behavioral responses to capsaicin (Fig. 6A,B). In addition, the pain behaviors (licking) evoked by a hindpaw injection of αβ-meATP (Fig. 6C) or formalin (Fig. 6D) were also significantly reduced in the OSM-/- mice.

  Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Reduced sensitivity to nociceptive stimuli in OSM-/- mice. A-D, Tests of chemical nociception. A, Duration of licking in response to intraplantar injection of capsaicin (1.0 μg; n = 6) is significantly reduced in mutant mice (black columns) compared with wild-type (white columns) and heterozygous mice (gray columns); the last two groups do not differ. B, Duration of licking in response to capsaicin at indicated doses (n = 5). C, Duration of licking in response to αβ-meATP (n = 6). D, Cumulative time spent licking the hindpaw after the subcutaneous injection of formalin (n = 6). Phase I, 0-10 min after injection; Phase II, 15-50 min after injection. E, Licking or jumping latency in the hot-plate assay (n = 6). F, Response latency to acute mechanical stimulus by tail clip (n = 6). G, H, Visceral pain responses (writhing) produced by the intraperitoneal injection of MgSO4 (G) or acetic acid (H) (n = 8-9 for both wild-type and mutant). NS, Not significant. *p < 0.05; **p < 0.02; ***p < 0.01; ****p < 0.001.

Next, we compared the thermoresponsive behavior of OSM+/+ and OSM-/- mice, because VR1 has been proposed to be a sensor for noxious heat (Cao et al., 1998). The latency of response to an acute thermal stimulus was measured using a 52 or 58°C hot plate. OSM-/- mice exhibited significantly longer response latencies than OSM+/+ mice at both 52 and 58°C (Fig. 6E). In addition, the latency to respond to a more intense mechanical stimulus (tail clip) was also significantly prolonged in the OSM-/- mice (Fig. 6F).

To determine whether the reduced pain responses in OSM-/- mice were generalized to noxious stimulation of other tissues, we assessed acute visceral pain behavior evoked by the intraperitoneal injection of MgSO4, which produces an immediate visceral pain response (abdominal writhing) independent of inflammation, and injection of acetic acid, which induces pain secondary to an inflammatory reaction. OSM-/- mice demonstrated a striking reduction in the number of abdominal writhes compared with wild-type in both tests of visceral pain (Fig. 6G,H).

Thus, behavioral acute nociceptive thresholds were affected markedly by an absence of OSM.

Discussion

The IL-6 family of cytokines plays important roles in a wide variety of biological systems by regulating cell growth and differentiation (Taga and Kishimoto, 1997; Heinrich et al., 1998). Among the members of this family, OSM and LIF are functionally and structurally related, and their genes are tightly linked in the same chromosomal location (Gearing, 1993; Gearing et al., 1993; Jeffery et al., 1993). In both central and peripheral nervous systems, LIF has been reported to play some important roles: the potentiation of glial development, the differentiation of neural crest precursor cells into sensory neurons, and the switching of neuropeptide production in sympathetic neurons (Turnley and Bartlett, 2000). However, the physiological function of OSM in the nervous system remains unknown.

Extensive studies on the neurotrophins during the development of DRG neurons have established that specific subsets of DRG neurons mediating different sensory modalities are supported by particular members of the neurotrophin family (Snider and Wright, 1996; Mogil et al., 2000). The majority of rodent DRG neurons, including all peptide-containing small-sized neurons, express TrkA and require nerve growth factor (NGF) for their survival during embryonic development. However, in half of the small-sized neurons (those that can bind the lectin isolectin B4), TrkA is downregulated during a few weeks after birth. These particular neurons change their expression of receptor tyrosine kinase from TrkA to c-Ret, suggesting a switch from NGF to glial cell line-derived neurotrophic factor (GDNF) responsiveness during postnatal development. It has been reported that LIF receptor starts to be expressed at an early embryonic stage (Qiu et al., 1994), and LIF and NGF synergistically induce the differentiation of mature sensory neurons from their precursors during early embryonic development (Murphy et al., 1993). In contrast, as described in the present study, OSMR-positive neurons began to appear at P0 and reached the adult level at P14, in the same manner as c-Ret expression. In addition, OSMR is expressed in the nonpeptidergic neurons (Tamura et al., 2003a), whereas LIF induces the differentiation to peptidergic neurons (Murphy et al., 1991, 1994). The distinct expression pattern of OSMR during development suggests that OSM may exert its function in concert with GDNF-family ligands.

Although LIF receptor was expressed in a variety of cells of the nervous system, no developmental abnormalities in the nervous system have been reported in LIF-/- mice, which display female sterility attributable to defective blastocyst implantation, postnatal growth retardation, and defects in hematopoiesis and thymocyte proliferation (Escary et al., 1993). In OSM-/- mice, VR1/P2X3-double-positive neurons were significantly decreased. Although the exact mechanism is unclear, some possibilities may be considered. One is that OSM may modify the expression of VR1 and P2X3. It was reported that the expression of VR1 and P2X3 in the DRGs increased by peripheral inflammation (Ji et al., 2002; Xu and Huang, 2002). In addition, OSM is produced by activated T cells, macrophages, polymorphonuclear neutrophils, and eosinophils, which participate in local inflammation (Modur et al., 1997; Grenier et al., 1999; Wallace et al., 1999; Tamura et al., 2002b). These findings suggest that OSM regulates the expression of VR1 and P2X3 in nociceptive neurons. Another possibility is that OSM may function as a postnatal survival factor to a specific subset of nociceptive neurons. In fact, the percentage of small-sized neurons to total DRG neurons was significantly reduced in OSM-/- mice.

Consistent with histological results, the present study revealed that OSM-/- mice displayed significantly reduced noxious responses in models of acute thermal, chemical, and visceral pain. Interestingly, a reduced response to mechanical pain was also observed in OSM-/- mice, whereas VR1-/- or P2X3-/- mice responded to mechanical pain normally (Caterina et al., 2000; Souslova et al., 2000). Although the mechanism remains unclear, OSM might play a role for the development of neurons responsive to mechanical stimuli.

Thus, our results indicate for the first time that OSM plays a key role for the postnatal stages of assembly of the neural pathways that detect noxious stimuli. Our data also suggest possible analgesic strategies based on the targeting of OSMR-positive neurons.

Footnotes

  • This work was supported by a Grant-in-Aid for Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology (15500264) and a Research Grant on Primary Areas from Wakayama Medical University. We thank Prof. Masahide Takahashi (Department of Pathology, Nagoya University School of Medicine, Nagoya, Japan) for the gift of the c-Ret antiserum.

  • Correspondence should be addressed to Dr. Yoshihiro Morikawa, Department of Anatomy and Neurobiology, Wakayama Medical University, 811-1 Kimiidera, Wakayama, 641-8509 Japan. E-mail: yoshim{at}wakayama-med.ac.jp.

  • Copyright © 2004 Society for Neuroscience 0270-6474/04/241941-07$15.00/0

  • ↵* Y.M. and S.T. contributed equally to this work.

References

  1. ↵
    Banner LR, Patterson PH, Allchorne A, Poole S, Woolf CJ (1998) Leukemia inhibitory factor is an anti-inflammatory and analgesic cytokine. J Neurosci 18: 5456-5462.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Cao YQ, Mantyh PW, Carlson EJ, Gillespie A-M, Epstein CJ, Basbaum AI (1998) Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392: 390-394.
    OpenUrlCrossRefPubMed
  3. ↵
    Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288: 306-313.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Coggeshall RE (1992) A consideration of neural counting methods. Trends Neurosci 15: 9-13.
    OpenUrlCrossRefPubMed
  5. ↵
    Dickenson AH, Sullivan AF (1987) Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci Lett 83: 207-211.
    OpenUrlCrossRefPubMed
  6. ↵
    Elson GCA, Lelievre E, Guillet C, Chevalier S, Plun-Favreau H, Froger J, Suard I, de Coignac AB, Delneste Y, Bonnefoy J-Y, Gauchat J-F, Gascan H (2000) CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci 3: 867-872.
    OpenUrlCrossRefPubMed
  7. ↵
    Escary JL, Perreau J, Dumenil D, Ezine S, Brulet P (1993) Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature 363: 361-364.
    OpenUrlCrossRefPubMed
  8. ↵
    Gearing DP (1993) The leukemia inhibitory factor and its receptor. Adv Immunol 53: 31-58.
    OpenUrlCrossRefPubMed
  9. ↵
    Gearing DP, Druck T, Huebner K, Overhauser J, Gilbert DJ, Copeland NG, Jenkins NA (1993) The leukemia inhibitory factor receptor (LIFR) gene is located within a cluster of cytokine receptor loci on mouse chromosome 15 and human chromosome 5p12-p13. Genomics 18: 148-150.
    OpenUrlCrossRefPubMed
  10. ↵
    Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo M-A, Chollet-Martin S (1999) Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93: 1413-1421.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Gundersen HJG, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen K, Nyengaard JR, Pakkenberg B, Sorensen FB, Vesterby A, West MJ (1988) Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. Acta Pathol Microbiol Immunol Scand 96: 379-394.
    OpenUrlCrossRef
  12. ↵
    Hara T, Tamura K, de Miguel M, Mukouyama Y-S, Kim H-J, Kogo H, Donovan PJ, Miyajima A (1998) Distinct roles of oncostatin M and leukemia inhibitory factor in the development of primordial germ cells and Sertoli cells in mice. Dev Biol 201: 144-153.
    OpenUrlCrossRefPubMed
  13. ↵
    Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L (1998) Interleukin-6-type cytokine signaling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314.
  14. ↵
    Jeffery E, Price V, Gearing DP (1993) Close proximity of the genes for leukemia inhibitory factor and oncostatin M. Cytokine 5: 107-111.
    OpenUrlCrossRefPubMed
  15. ↵
    Ji R-R, Samad TA, Jin S-X, Schmoll R, Woolf CJ (2002) p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron 36: 57-68.
    OpenUrlCrossRefPubMed
  16. ↵
    Kamiya A, Kinoshita T, Ito Y, Matsui T, Morikawa Y, Senba E, Nakashima K, Taga T, Yoshida K, Kishimoto T, Miyajima A (1999) Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 18: 2127-2136.
    OpenUrlAbstract
  17. ↵
    Kishimoto T, Akira S, Narazaki M, Taga T (1995) Interleukin-6 family of cytokines and gp130. Blood 86: 1243-1254.
    OpenUrlFREE Full Text
  18. ↵
    Lecomte M-J, Basseville M, Landon F, Karpov V, Fauquet M (1998) Transcriptional activation of the mouse peripherin gene by leukemia inhibitory factor: involvement of STAT proteins. J Neurochem 70: 971-982.
    OpenUrlPubMed
  19. ↵
    Matsui T, Kinoshita T, Morikawa Y, Tohya K, Katsuki M, Ito Y, Kamiya A, Miyajima A (2002) K-ras mediates cytokine-induced formation of E-cadherin-based adherens junctions during liver development. EMBO J 21: 1021-1030.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Miyajima A, Kinoshita T, Tanaka M, Kamiya A, Mukouyama Y, Hara T (2000) Role of oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev 11: 177-183.
    OpenUrlCrossRefPubMed
  21. ↵
    Modur V, Feldhaus MJ, Weyrich AS, Jicha DL, Prescott SM, Zimmerman GA, McIntyre TM (1997) Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules. J Clin Invest 100: 158-168.
    OpenUrlCrossRefPubMed
  22. ↵
    Mogil JS, Yu L, Basbaum AI (2000) Pain genes? Natural variation and transgenic mutants. Annu Rev Neurosci 23: 777-811.
    OpenUrlCrossRefPubMed
  23. ↵
    Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS, Cosman D (1996) Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635-32643.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Mukouyama Y, Hara T, Xu M, Tamura K, Donovan PJ, Kim H, Kogo H, Tsuji K, Nakahata T, Miyajima A (1998) In vitro expansion of murine multipotential hematopoietic progenitors from the embryonic aorta-gonad-mesonephros region. Immunity 8: 105-114.
    OpenUrlCrossRefPubMed
  25. ↵
    Murphy M, Reid K, Hilton DJ, Bartlett PF (1991) Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci USA 88: 3498-3501.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Murphy M, Reid K, Brown MA, Bartlett PF (1993) Involvement of leukemia inhibitory factor and nerve growth factor in the development of dorsal root ganglion neurons. Development 117: 1173-1182.
    OpenUrlAbstract
  27. ↵
    Murphy M, Reid K, Ford M, Furness JB, Bartlett PF (1994) FGF2 regulates proliferation of neural crest cells, with subsequent neuronal differentiation regulated by LIF or related factors. Development 120: 3519-3528.
    OpenUrlAbstract
  28. ↵
    Qiu L, Bernd P, Fukada K (1994) Cholinergic neuronal differentiation factor (CDF)/leukemia inhibitory factor (LIF) binds to specific regions of the developing nervous system in vivo. Dev Biol 163: 516-520.
    OpenUrlPubMed
  29. ↵
    Senaldi G, Varnum BC, Sarmiento U, Starnes C, Lile J, Scully S, Guo J, Elliott G, McNinch J, Shaklee CL, Freeman D, Manu F, Simonet WS, Boone T, Chang M-S (1999) Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proc Natl Acad Sci USA 96: 11458-11463.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    Snider WD, Wright DE (1996) Neurotrophins cause a new sensation. Neuron 16: 229-232.
    OpenUrlCrossRefPubMed
  31. ↵
    Souslova V, Cesare P, Ding Y, Akopian AN, Stanfa L, Suzuki R, Carpenter K, Dickenson A, Boyce S, Hill R, Nebenuis-Oosthuizen D, Smith AJ, Kidd EJ, Wood JN (2000) Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407: 1015-1017.
    OpenUrlCrossRefPubMed
  32. ↵
    Sugiura S, Lahav R, Han J, Kou S-Y, Banner LR de Pablo F, Patterson PH (2000) Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci 12: 457-466.
    OpenUrlCrossRefPubMed
  33. ↵
    Sun Y, Zigmond RE (1996) Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons. Eur J Neurosci 8: 2213-2220.
    OpenUrlCrossRefPubMed
  34. ↵
    Taga T, Kishimoto T (1997) Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 15: 797-819.
    OpenUrlCrossRefPubMed
  35. ↵
    Tamura S, Morikawa Y, Tanaka M, Miyajima A, Senba E (2002a) Developmental expression pattern of oncostatin M receptor β in mice. Mech Dev 115: 127-131.
    OpenUrlCrossRefPubMed
  36. ↵
    Tamura S, Morikawa Y, Miyajima A, Senba E (2002b) Expression of oncostatin M in hematopoietic organs. Dev Dyn 225: 327-331.
    OpenUrlCrossRefPubMed
  37. ↵
    Tamura S, Morikawa Y, Miyajima A, Senba E (2003a) Expression of oncostatin M receptor β in a specific subset of nociceptive sensory neurons. Eur J Neurosci 17: 2287-2298.
    OpenUrlCrossRefPubMed
  38. ↵
    Tamura S, Morikawa Y, Senba E (2003b) Localization of oncostatin M receptor β in adult and developing CNS. Neuroscience 119: 991-997.
    OpenUrlCrossRefPubMed
  39. ↵
    Tsuda M, Shigemoto-Mogami Y, Ueno S, Koizumi S, Ueda H, Iwanaga T, Inoue K (2002) Downregulation of P2X3 receptor-dependent sensory functions in A/J inbred mouse strain. Eur J Neurosci 15: 1444-1450.
    OpenUrlCrossRefPubMed
  40. ↵
    Turnley AM, Bartlett PF (2000) Cytokines that signal through the leukemia inhibitory factor receptor-β complex in the nervous system. J Neurochem 74: 889-899.
    OpenUrlCrossRefPubMed
  41. ↵
    Wallace PM, MacMaster JF, Rouleau KA, Brown TJ, Loy JK, Donaldson KL, Wahl AF (1999) Regulation of inflammatory responses by oncostatin M. J Immunol 162: 5547-5555.
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Xu G-Y, Huang L-Y (2002) Peripheral inflammation sensitizes P2X receptor-mediated responses in rat dorsal root ganglion neurons. J Neurosci 22: 93-102.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    Yoshimura A, Ichihara M, Kinjyo I, Moriyama M, Copeland NG, Gilbert DJ, Jenkins NA, Hara T, Miyajima A (1996) Mouse oncostatin M: an immediate early gene induced by multiple cytokines through the JAK-STAT5 pathway. EMBO J 15: 1055-1063.
    OpenUrlPubMed
  44. ↵
    Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lioubin MN, Todaro GJ (1986) Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. Proc Natl Acad Sci USA 83: 9739-9743.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Zhong J, Dietzel ID, Wahle P, Kopf M, Heumann R (1999) Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 19: 4305-4313.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

The Journal of Neuroscience: 24 (8)
Journal of Neuroscience
Vol. 24, Issue 8
25 Feb 2004
  • Table of Contents
  • About the Cover
  • Index by author
  • AbstractBrowser.pdf
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia
Yoshihiro Morikawa, Shinobu Tamura, Ken-ichi Minehata, Peter J. Donovan, Atsushi Miyajima, Emiko Senba
Journal of Neuroscience 25 February 2004, 24 (8) 1941-1947; DOI: 10.1523/JNEUROSCI.4975-03.2004

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Essential Function of Oncostatin M in Nociceptive Neurons of Dorsal Root Ganglia
Yoshihiro Morikawa, Shinobu Tamura, Ken-ichi Minehata, Peter J. Donovan, Atsushi Miyajima, Emiko Senba
Journal of Neuroscience 25 February 2004, 24 (8) 1941-1947; DOI: 10.1523/JNEUROSCI.4975-03.2004
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • Loss of motor cortical inputs to the red nucleus after central nervous system disorders in non-human primates
  • Astrocytes transplanted during early postnatal development integrate, mature, and survive long-term in mouse cortex
  • CDK5/p35-Dependent Microtubule Reorganization Contributes to Homeostatic Shortening of the Axon Initial Segment
Show more Development/Plasticity/Repair
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.